Thursday 19th October 2017

09:45 Thursday 19th

Room F Sponsored Symposium 09:45 → 11:15
Current management of uterine fibroids with ulipristal acetate (Sponsored by Gedeon Richter))

Chairperson/s: Joaquim Calaf Alsina

  • Perinne Capmas Pre-operative use of ulipristal acetate
  • Gracia Meritxell Medical management of fibroids in perimenopausal women
  • Mathieu Luyckx Long-term non-surgical control with ulipristal acetate in women of reproductive age enabling pregnancy

13:30 Thursday 19th

Room H Sponsored Lunch Symposium 13:30 → 15:15
Evolution of vaginal ring in contraception- Sponsored by Exeltis –

Chairperson/s: Johannes Bitzer , Inaki Lete

  • Rosella Nappi Benefits of vaginal ring in contraception.
  • Christian Egarter The evolution of the vaginal ring in contraception.
  • Artur Jakimiuk New vaginal ring patient acceptance

16:30 Thursday 19th

Room F Sponsored Symposium 16:30 → 18:00
Novel approaches in pregnancy care and cervical cancer screening: clinical evidence meets innovation -Sponsored by Roche Diagnostics International –

Chairperson/s: Juan Acuna

  • Jose Luis Bartha Rasero Non-invasive prenatal testing (NIPT) as primary screening in the first trimester of pregnancy
  • Holger Stepan sFlt-1 / PlGF ratio: a novel tool for the management of women with suspected preeclampsia
  • Marta del Pino Saladrigues Optimizing the screening strategies: we can do better

Friday 20th October 2017

09:45 Friday 20th

Room J Sponsored Symposium 09:45 → 11:15
Premature Rupture of Membrane (PROM) and Preterm PROM (pPROM) – state of the art diagnostic tools – Sponsored by PRIMA Lab SA –

Chairperson/s: Andrea R. Genazzani

  • Hadar Kessary Shoham Diagnostic tools to assess unexplained vaginal wetness in pregnancy
  • Vered Pardo Yissar R&D in the OBGYN arena
  • Guido Gatti The UK experience – NICE/NHS guide lines for amniotic leak detection during pregnancy

13:30 Friday 20th

Room H Sponsored Lunch Symposium 13:30 → 15:15
Flexible choice for women in long-term contraceptive care- Sponsored by Gedeon Richter –

Chairperson/s: Andrea R. Genazzani

  • Andrea R. Genazzani Increasing importance of long-term reversible contraception
  • J Michel Foidart LNG IUS – an intrauterine system specifically designed to meet women’s expectations
  • Mitchell Creinin Access IUS Multicentre Study clinical data on the ongoing LNG IUS trial
  • Paula E. Briggs LNG IUS more choice for women, a clinician’s story

15:45 Friday 20th

Room F Sponsored Debate 15:45 → 16:45
New therapeutic proposals for PCOS and female infertility- Sponsored by Lo.Li Pharma-

Chairperson/s: Pedro Barri

  • Fabio Facchinetti Physiology and Therapeutic Use of Inositols In PCOS
  • Scott Roseff Integrative Support for Women Undergoing ART: Myo-Inositol and Melatonin Combined


Sponsorship Opportunities

It is still possible to be one of the sponsors of the 12th Congress of the European Society of Gynecological Endocrinology.

Request information


Choose your area of interest:

Exhibition Area:

Other Sponsorship Opportunities

Personal data collected directly and/or through third parties by controller and processor Biomedical Technologies, Main Office in Cagliari Via Cugia 1, are processed in printed, computing and telematic form for fulfilling contractual and lawful obligations as well as for the effective handing of business relations. The email addresses provided may be used by Biomedical Technologies to send advertising materials on events similar to those subject of the present business relations. The non-submittal of data, where not compulsory, will be evaluated from case to case by the controller and the resulting decisions to be made will take into account the importance of the required data in respect of the business relations, management. Data may be disclosed in Italy and/or abroad, strictly in accordance with the above-mentioned purposes, and consequently processed, only in relation to the mentioned purpose, by other persons: professionals and consultants as well as by persons allowed to access to your personal data according to National or Community regulations. If necessary, for the above-mentioned reasons, your data may be disclosed to third parties. For the same reasons, our partners and/or employees may process your data in their capacity of executors or processors. The persons concerned may exercise all the rights set forth in art. 7 of L.n. 196/2003 (including the rights of data access, corrections, updating, objects to data processing and cancellation). The processor “pro tempore” is the legal representative of the company.